Dolnośląska Zielona Dolinasp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2018-01-16
Share capital
3 549 454,00 PLN
Registered address
ul. Strzegomska 138/4, 54-429 Wrocław, Poland
Electronic delivery address
AE:PL-88316-41281-DESEI-22
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 18 days early.
- 202513/07/2026
- 202408/07/2025
- 202313/07/2024
- 202230/06/2023
- 202112/07/2022
- 202030/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 164.02kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD -165.39kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 228.48kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 39.60kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Katarzyna Stoncel – Management Board Member
Manner of representation
A member of the management board is authorised to submit declarations of will on behalf of the company independently.
Supervisory board
Anna Ogły – Supervisory Board Member
Barbara Kutkowska – Supervisory Board Member
Dominika Mańkowska – Supervisory Board Member
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Uniwersytet Przyrodniczy we Wrocławiu | 206 | $958,793.63 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-08-20.
71 1090 1522 0000 0001 3564 3775
36 1090 1522 0000 0001 5226 7974
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| Phage Consultantssp. z o.o. | $193,130.82 | phageconsultants.com | ||
| Bactremsp. z o.o. | $181,958.36 | bactrem.pl | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | ||
| UveraS.A. | $155,384.29 | uvera.eu | ||
| GenomtecS.A. | $54,746.36 | genomtec.com | ||
| Centrum Transferu Technologii Meditransfer Iitdsp. z o.o. | $228.56 | iitd.pan.wroc.pl | ||
| Olenasp. z o.o. | – | imsolutions.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-03-16 | Share capital change (3,187,429.00 PLN → 3,549,454.00 PLN) | |
| 2025-08-06 | Address change (Ul. Strzegomska 42ab, 53-611, Wrocław → Ul. Strzegomska 138/4, 54-429, Wrocław) | |
| 2025-08-06 | Share capital change (2,962,169.00 PLN → 3,187,429.00 PLN) | |
| 2024-07-15 | Share capital change (2,912,290.00 PLN → 2,962,169.00 PLN) | |
| 2024-06-17 | Share capital change (2,862,044.40 PLN → 2,912,290.00 PLN) |
FAQ
The main business activity of Dolnośląska Zielona Dolina focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on January 16, 2018.
The headquarters is located at: ul. Strzegomska 138, 54-429 Wrocław.
The share capital of the company is PLN 3,549,454 (approx. $958,794).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $179,345, representing a decrease of 22.7% compared to 2023.
No, the company recorded a net loss of $65,166 in 2024. For comparison, in 2023 the loss was $35,752, meaning the company increased its loss by 73.1%.
The largest operating cost category falls under employee remuneration. This category amounted to $97,943 in 2024, representing 40% of all operating expenses.
Last updated: 2026-10-07